Cell Therapeutics Inc. Soars Again

Shares of Cell Therapeutics (NASDAQ: CTIC  ) had a monster of a day on the market today, up 20% at their height before settling back down to a 12% gain for the day. In this video, Motley Fool health-care analyst David Williamson looks at some positive news out of Europe that has been driving up shares today about the company's non-Hodgkin lymphoma drug, Pixuvri. David also looks at more good news for the company, after the FDA released a partial clinical hold on Cell Therapeutics' leukemia drug Tosedostat, which is in phase 2 trials.

However, David warns that despite some recent good news for the company and the stock's incredible run recently, there are serious pitfalls for investors to consider here. He notes that despite the company's seemingly robust pipeline on the surface, some of its pipeline drugs, such as Pacritinib, have a checkered past. As well, he warns that the company has a track record of diluting shareholder equity, and with shares having doubled in price over the last year, another capital raise may not be far over the horizon.

A biotech game-changer
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that Big Pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2785219, ~/Articles/ArticleHandler.aspx, 9/23/2014 2:41:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement